Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Treatment and Research|May 17, 2026
Metabolic Cross Talk in the Tumor MicroenvironmentChinmay Das, Somya Ranjan Dash, Biswajit Das, et al.
Plos One|January 11, 2018
Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patientsSnekha Thakran, Subhajit Chatterjee, Meenakshi Singhal, et al.
DNA Repair|June 18, 2021
Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assemblySefinew Molla, Subhajit Chatterjee, Chinmayee Sethy, et al.
Molecular Pharmaceutics|November 27, 2025
Harnessing Nanotechnology to Rewire Lipid Metabolism: A Novel Therapeutic Avenue for Brain CancerSomya Ranjan Dash, Krushna Chandra Hembram, Subhajit Chatterjee, et al.
Cellular Signalling|December 29, 2020
PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla, et al.
IEEE Journal of Biomedical and Health Informatics|October 15, 2025
Evaluating Hallucination and Diagnostic Reliability of LLMs on Medical Image-Based Multiple Choice TasksDebapriya Hazra, Shayani Mukherjee, Suman Kumar, et al.
The Journal of Nutritional Biochemistry|March 11, 2021
Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophagesRajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram, et al.
Experimental Cell Research|September 8, 2022
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathwaySaptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Pathology Oncology Research : POR|November 27, 2019
PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER CascadeSefinew Molla, Krushna Chandra Hembram, Subhajit Chatterjee, et al.
Journal of Cancer Research and Clinical Oncology|August 13, 2022
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trappingSubhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, et al.
Pageof 3